414 related articles for article (PubMed ID: 24713096)
1. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.
Parker CE; Borchers CH
Mol Oncol; 2014 Jun; 8(4):840-58. PubMed ID: 24713096
[TBL] [Abstract][Full Text] [Related]
2. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
[TBL] [Abstract][Full Text] [Related]
3. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
Dittrich J; Ceglarek U
Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
[TBL] [Abstract][Full Text] [Related]
4. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
5. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
Mermelekas G; Vlahou A; Zoidakis J
Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
[TBL] [Abstract][Full Text] [Related]
6. Targeted proteomics for cancer biomarker verification and validation.
Ogata S; Masuda T; Ito S; Ohtsuki S
Cancer Biomark; 2022; 33(4):427-436. PubMed ID: 35491770
[TBL] [Abstract][Full Text] [Related]
7. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
Ang CS; Baker MS; Nice EC
Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
[TBL] [Abstract][Full Text] [Related]
9. Imaging mass spectrometry in biomarker discovery and validation.
Schwamborn K
J Proteomics; 2012 Aug; 75(16):4990-4998. PubMed ID: 22749859
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
11. Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies.
Percy AJ; Yang J; Hardie DB; Chambers AG; Tamura-Wells J; Borchers CH
Methods; 2015 Jun; 81():24-33. PubMed ID: 25858257
[TBL] [Abstract][Full Text] [Related]
12. Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.
Percy AJ; Byrns S; Chambers AG; Borchers CH
Expert Rev Proteomics; 2013 Dec; 10(6):567-78. PubMed ID: 24206229
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
14. Feature Selection Methods for Protein Biomarker Discovery from Proteomics or Multiomics Data.
Shi Z; Wen B; Gao Q; Zhang B
Mol Cell Proteomics; 2021; 20():100083. PubMed ID: 33887487
[TBL] [Abstract][Full Text] [Related]
15. Targeted proteomics: a bridge between discovery and validation.
Harlan R; Zhang H
Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
[TBL] [Abstract][Full Text] [Related]
16. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
Chou CY; Chang CT; Chen CJ
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
Ryu J; Thomas SN
Molecules; 2021 May; 26(9):. PubMed ID: 34063568
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery: success as a function of risk mitigation.
Weiser S
Scand J Clin Lab Invest Suppl; 2016; 245():S12-6. PubMed ID: 27426622
[TBL] [Abstract][Full Text] [Related]
19. Standardization approaches in absolute quantitative proteomics with mass spectrometry.
Calderón-Celis F; Encinar JR; Sanz-Medel A
Mass Spectrom Rev; 2018 Nov; 37(6):715-737. PubMed ID: 28758227
[TBL] [Abstract][Full Text] [Related]
20. Qualification and Verification of Protein Biomarker Candidates.
Zhao Y; Brasier AR
Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
